Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GameStop Corp. (GME) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance

GameStop Corp.Trade
Halozyme Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

GameStop Corp. vs Halozyme Therapeutics Inc. Common Stock — how do they compare? GameStop Corp. trades at $26.57 (market cap $12.75B), while Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B). The key difference: GameStop Corp. and Halozyme Therapeutics Inc. Common Stock are close in size by market cap, and GameStop Corp. is more actively traded (13,026,993 versus 2,179,278). Which is the better fit depends on your goals — on Pluang, investors hold GameStop Corp. for 62 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.

GMEHALO
Market Cap
$12.75B$12.58B
Volume
13,026,9932,179,278
Sector
Consumer CyclicalHealth
52-Week High
$26.53$115.22
52-Week Low
$17.87$61.63
Typical Hold Time
62 Days1 Days
Enterprise Value
$12.03B$14.49B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

GameStop Corp.

GME trades at $26.56, up 8.06% over 24 hours, with a bullish technical signal supported by moving averages. Recent earnings show mixed results, beating estimates in Q4 2025 and Q1 2026 but missing in Q2 2026. The company reported net income of $131.3 million in 2025, a significant turnaround from prior losses, while revenue declined to $3.82 billion. Strong insider buying by CEO Ryan Cohen and directors has fueled positive sentiment, though analyst consensus remains cautious with a majority hold rating.

The outlook for GME hinges on execution of its strategic pivot to high-margin collectibles and leveraging its $4.77 billion cash position. Key risks include revenue volatility, competitive pressures, and dependence on insider confidence. Upside potential exists if earnings growth sustains, but investors face uncertainty from inconsistent profitability and high valuation multiples relative to historical performance.

Halozyme Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GME
16% Buy84% Sell
Avg holding period · 62 Days
HALO

No sentiment data available yet.

Top news

Latest headlines on both assets

About GameStop Corp.

Global Market Group Ltd. operates an Internet website that connects Chinese manufacturers with international buyers. The Company's customers can post company profiles and product information in standardized formats; post product listings; and trade leads.

Read more on GME →

About Halozyme Therapeutics Inc. Common Stock

Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.

Read more on HALO →